Legend Biotech Corp (LEGN)
45.41
-0.52
(-1.13%)
USD |
NASDAQ |
May 03, 16:00
45.42
0.00 (0.00%)
Pre-Market: 20:00
Legend Biotech Profit Margin (Quarterly): -182.2% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -182.2% |
September 30, 2023 | -64.79% |
June 30, 2023 | -271.6% |
March 31, 2023 | -308.5% |
December 31, 2022 | -491.7% |
September 30, 2022 | -310.5% |
June 30, 2022 | -1.61K% |
March 31, 2022 | -64.53% |
December 31, 2021 | -586.3% |
September 30, 2021 | -742.8% |
Date | Value |
---|---|
June 30, 2021 | -241.7% |
March 31, 2021 | |
December 31, 2020 | -51.67% |
September 30, 2020 | -566.5% |
June 30, 2020 | -1.16K% |
March 31, 2020 | -383.1% |
December 31, 2019 | -328.8% |
September 30, 2019 | -157.3% |
June 30, 2019 | -285.5% |
March 31, 2019 | -123.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.61K%
Minimum
Jun 2022
-51.67%
Maximum
Dec 2020
-434.1%
Average
-309.5%
Median
Profit Margin (Quarterly) Benchmarks
Johnson & Johnson | 15.22% |
Bristol-Myers Squibb Co | -100.4% |
2seventy bio Inc | -531.8% |
Exelixis Inc | 8.78% |
Alnylam Pharmaceuticals Inc | -13.34% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -48.03% |
Return on Assets | -31.76% |
Return on Invested Capital | -38.39% |
Gross Profit Margin (Quarterly) | 59.16% |
Operating Margin (Quarterly) | -150.8% |
Return on Net Operating Assets | -129.1% |